Published in Curr Oncol on July 01, 2009
Benefits and adverse effects of endocrine therapy. Ann Oncol (2010) 0.88
Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice? Springerplus (2014) 0.86
Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients. Ann Behav Med (2013) 0.85
17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats. Int J Breast Cancer (2011) 0.80
Estrogen receptor testing and 10-year mortality from breast cancer: A model for determining testing strategy. J Pathol Inform (2012) 0.76
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med (2003) 13.81
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med (2005) 12.99
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med (2004) 10.41
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol (2008) 8.70
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst (2003) 8.66
The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum (1995) 7.97
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol (2007) 7.45
Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc (2003) 7.38
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst (2005) 5.92
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst (2005) 5.55
Osteoporosis. Lancet (2006) 5.40
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet (2000) 4.43
Estrogen and the risk of breast cancer. N Engl J Med (2001) 4.39
Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther (2004) 3.84
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol (2003) 3.71
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol (2006) 2.74
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol (2007) 2.24
Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum (2005) 2.16
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol (2004) 1.95
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230). J Bone Miner Res (2006) 1.80
Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med (1991) 1.55
Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med (2003) 1.51
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol (2006) 1.47
Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients. Clin Breast Cancer (2007) 1.24
Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer (2005) 1.23
Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol (2006) 1.23
Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women. Breast Cancer Res (2007) 1.22
Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment. J Natl Cancer Inst (1994) 1.19
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. Int J Clin Pract (2007) 1.17
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L). Ann Oncol (2005) 1.08
Osteopenia and osteoporosis in women with breast cancer. Semin Oncol (2003) 1.08
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane. Bone (2006) 0.99
The effects of aromatase inhibitors on lipids and thrombosis. Br J Cancer (2005) 0.98
Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol (2007) 0.95
Canadian Consensus Conference on menopause, 2006 update. J Obstet Gynaecol Can (2006) 0.92
Management of arthralgias associated with aromatase inhibitor therapy. Curr Oncol (2007) 0.92
The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporos Int (2004) 0.88
Clinical management of adverse events in adjuvant therapy for hormone-responsive early breast cancer. Ann Oncol (2007) 0.86
Effects of third-generation aromatase inhibitors on bone. Eur J Cancer (2006) 0.85
Molecular Action and Clinical Relevance of Aromatase Inhibitors. Oncologist (1998) 0.83
Has tamoxifen had its day? Breast Cancer Res (2002) 0.81
Long-term mortality of women with a diagnosis of breast cancer. Oncology (2002) 0.81
Vascular effects of aromatase inhibitors: data from clinical trials. J Steroid Biochem Mol Biol (2005) 0.77
Inappropriate ATAC on tamoxifen. Lancet Oncol (2008) 0.77
The molecular perspective: tamoxifen and the estrogen receptor. Oncologist (2002) 0.76
Optimising bone health in survivors of breast cancer. Lancet Oncol (2007) 0.76
Arabidopsis transcription factors: genome-wide comparative analysis among eukaryotes. Science (2000) 11.68
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science (1994) 4.22
Auxin-induced expression of the soybean GH3 promoter in transgenic tobacco plants. Plant Mol Biol (1991) 3.67
'Valuing people'--a new strategy for learning disability for the 21st century: how may it impinge on primary care? Br J Gen Pract (2001) 3.04
Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesth Analg (1995) 2.83
The human U1A snRNP protein regulates polyadenylation via a direct interaction with poly(A) polymerase. Cell (1994) 2.70
Serum leptin and vascular risk factors in obstructive sleep apnea. Chest (2000) 2.53
Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature (1986) 2.25
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A (1991) 2.16
Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit. Nature (1986) 2.13
Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol (1999) 2.05
Isolation and expression of cDNA clones encoding mammalian poly(A) polymerase. EMBO J (1991) 1.93
Meta-analysis of randomised controlled trials of nicotine chewing-gum. Lancet (1987) 1.90
Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A (1990) 1.86
Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol (1997) 1.82
Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor. J Neurosci (1985) 1.80
Monocyte adherence results in selective induction of novel genes sharing homology with mediators of inflammation and tissue repair. J Immunol (1990) 1.80
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia (2006) 1.77
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection (2009) 1.64
Remote vibration measurement: a wireless passive surface acoustic wave resonator fast probing strategy. Rev Sci Instrum (2012) 1.55
Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg (1994) 1.54
Optical systems for in vivo molecular imaging of cancer. Technol Cancer Res Treat (2003) 1.44
The ADONIS experiment. Health Libr Rev (1989) 1.41
Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene (1990) 1.39
The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol (1990) 1.39
Sexual abuse and suicidal issues in Australian young people. An interim report. Aust Fam Physician (1999) 1.38
Cimetidine-associated adverse reaction. DICP (1990) 1.38
The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem (1998) 1.38
Communication between patients with breast cancer and health care providers. Determinants and implications. Cancer (1993) 1.30
Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev (1992) 1.27
Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiography. Am Heart J (1982) 1.25
Interleukin-3-dependent expression of the c-myc and c-fos proto-oncogenes in hemopoietic cell lines. EMBO J (1986) 1.24
Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment. Br Heart J (1982) 1.24
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer (2004) 1.22
5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology (1997) 1.22
Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo. Transplantation (1986) 1.20
The contribution of founder mutations to early-onset breast cancer in French-Canadian women. Clin Genet (2009) 1.17
Improving the health of people with intellectual disabilities: outcomes of a health screening programme after 1 year. J Intellect Disabil Res (2006) 1.16
Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol (2004) 1.14
Non-otogenic cerebral abscess. J Neurol Neurosurg Psychiatry (1973) 1.13
Evolution of Drosophila repetitive-dispersed DNA. J Mol Evol (1983) 1.13
An experimental methodology for analysis of child pedestrian behavior. Pediatrics (1969) 1.13
Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Curr Oncol (2006) 1.11
Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro. FEBS Lett (2008) 1.10
Endothelium-dependent relaxation in isolated human arteries and veins. Clin Sci (Lond) (1987) 1.08
Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am J Cardiol (1983) 1.08
Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model. Graefes Arch Clin Exp Ophthalmol (2009) 1.08
[Recent aspects of blood culture technics]. Ann Biol Clin (Paris) (1987) 1.08
Language comprehension in boys with fragile X syndrome and boys with Down syndrome. J Intellect Disabil Res (2007) 1.08
Early and late results of excision of choledochal cysts. J Pediatr Surg (1997) 1.08
Role of gamma-carboxyglutamic acid. Cation specificity of prothrombin and factor X-phospholipid binding. J Biol Chem (1976) 1.07
Vaccination and early protection against non-host-specific Salmonella serotypes in poultry: exploitation of innate immunity and microbial activity. Epidemiol Infect (2005) 1.06
Lower limb blocks following general anaesthesia. Anaesthesia (2003) 1.06
Propylene glycol: a potentially toxic vehicle in liquid dosage form. J Pediatr (1970) 1.06
Comparative macrorestriction and RFLP analysis of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis isolates from man, pig, and cattle. Vet Microbiol (2006) 1.05
Demographic correlates of psychotic-like experiences in young Australian adults. Acta Psychiatr Scand (2008) 1.04
The role of trauma in disc protrusion. N Z Med J (1978) 1.04
The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro. Br J Clin Pharmacol (1986) 1.04
Gender differences in the relationship between depression and suicidal ideation in young adolescents. Aust N Z J Psychiatry (2001) 1.04
Analysis and significance of mRNA in human ejaculated sperm from normozoospermic donors: relationship to sperm motility and capacitation. Mol Hum Reprod (2004) 1.03
Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study. Int J Cancer (1993) 1.03
3-hydroxy-3-methylglutaryl coenzyme A reductase of Sulfolobus solfataricus: DNA sequence, phylogeny, expression in Escherichia coli of the hmgA gene, and purification and kinetic characterization of the gene product. J Bacteriol (1997) 1.03
Long-term effects of myotomy and partial fundoplication for esophageal achalasia. Dis Esophagus (2002) 1.03
Chronic recurrent right ventricular tachycardia in patients without ischemic heart disease: clinical, hemodynamic, and angiographic findings. Am Heart J (1983) 1.02
The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro. Br J Clin Pharmacol (1987) 1.01
Exhaled nitric oxide: the effects of age, gender and body size. Lung (2001) 1.01
Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes. Inflamm Res (2003) 1.00
Invasion of rabbit ileal tissue by Enterobacter cloacae varies with the concentration of OmpX in the outer membrane. Infect Immun (1994) 1.00
DNA sequences flanking the starts of the hsp 70 and alpha beta heat shock genes are homologous. Dev Biol (1981) 0.99
Sputum elastase in steady-state bronchiectasis. Chest (2000) 0.99
Gastrokine 1 expression in patients with and without Helicobacter pylori infection. Dig Liver Dis (2006) 0.99
Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol (2001) 0.99
Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients. Br J Haematol (2004) 0.98
Effect of butter, mono- and polyunsaturated fatty acid-enriched butter, trans fatty acid margarine, and zero trans fatty acid margarine on serum lipids and lipoproteins in healthy men. J Lipid Res (1993) 0.98
DNA bending induced by specific interaction of decamer binding proteins with immunoglobulin gene control sequences. J Ultrastruct Mol Struct Res (1989) 0.98
Self-monitoring, self-administration of token reinforcement, and goal-setting to improve work rates with retarded clients. Int J Rehabil Res (1980) 0.98
Medical data mining using evolutionary computation. Artif Intell Med (1999) 0.97
Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone (1996) 0.97
Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol (2005) 0.97
Transitional hypothermia in preterm newborns. J Perinatol (2007) 0.96
Recurrent pain of a pseudotabetic variety after laminectomy for lumbar disc lesion. J Neurol Neurosurg Psychiatry (1980) 0.96
Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol (2007) 0.95
The rabbit kidney tubule utilizes glucose for glutamine synthesis. A 13C NMR study. J Biol Chem (1994) 0.95
Influence of metal thickness on phase velocity and thermal sensitivity of SAW devices. IEEE Trans Ultrason Ferroelectr Freq Control (2001) 0.95
In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units. Vaccine (2010) 0.94
Identification of genes differentially expressed in V79 cells grown as multicell spheroids. Int J Radiat Biol (2002) 0.94
Physicochemical characteristics of Listeria specific antigen 2. J Gen Microbiol (1980) 0.94
Comparison of two reinforcement strategies in vocational-skill training of mentally retarded persons. Am J Ment Defic (1980) 0.94
Pure tone thresholds for the rhesus monkey. Hear Res (1978) 0.93
A longitudinal study of dental experience during the first four years of military experience. Mil Med (2008) 0.93
Effects of chronic ethanol consumption on the catabolism of chylomicron triacylglycerol and cholesteryl ester in the rat. Atherosclerosis (1977) 0.93
T cell regulation in adult transplantation tolerance. J Immunol (1996) 0.93
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol (2004) 0.92
Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol (2004) 0.92
[Translocation 8-22 with no length change and partial trisomy for 8q. Detection by heat denaturation]. Exp Cell Res (1972) 0.92
Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol (1981) 0.92
Sequential regional phase mapping of radionuclide gated biventriculograms in patients with sustained ventricular tachycardia: close correlation with electrophysiologic characteristics. Am Heart J (1982) 0.91
Methanol poisoning. I. The role of formic acid in the development of metabolic acidosis in the monkey and the reversal by 4-methylpyrazole. Biochem Med (1975) 0.91
Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro. Clin Sci (Lond) (1988) 0.91
The rabbit kidney tubule simultaneously degrades and synthesizes glutamate. A 13C NMR study. J Biol Chem (1997) 0.91